HYPERREACTIVITY OF PLATELETS TO SEROTONIN (5-HYDROXYTRYPTAMINE) IN PATIENTS WITH CARDIOVASCULAR-DISEASES - INFLUENCE OF KETANSERIN, A SEROTONIN S2-RECEPTOR ANTAGONIST

被引：13

作者：

DECREE, J

ROELS, V

VERHAEGEN, H

机构：

来源：

DRUGS | 1988年 / 36卷

关键词：

D O I：

10.2165/00003495-198800361-00015

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：87 / 91

页数：5

共 12 条

[1] CORRECTION BY KETANSERIN OF THE PLATELET-MEDIATED INHIBITION OF PERIPHERAL COLLATERAL CIRCULATION IN THE CAT - MEASUREMENT OF BLOOD-FLOW WITH RADIOACTIVE MICROSPHERES [J].

DECLERCK, F ;

LOOTS, W ;

JAGENEAU, A ;

NEVELSTEEN, A .

DRUG DEVELOPMENT RESEARCH, 1986, 8 (1-4) :149-158

[2] PLATELET-MEDIATED VASCULAR CONTRACTIONS - INHIBITION OF THE SEROTONERGIC COMPONENT BY KETANSERIN [J].

DECLERCK, F ;

VANNUETEN, JM .

THROMBOSIS RESEARCH, 1982, 27 (06) :713-727

[3]

DECLERCK F, 1982, 5 HYDROXYTRYPTAMINE, P83

[4]

DECREE J, 1984, LANCET, V2, P775

[5]

DECREE J, 1985, AGENTS ACTIONS, V16, P313

[6] ADENOSINE-DIPHOSPHATE INDUCED PLATELET-AGGREGATION IN MYOCARDIAL-INFARCTION AND ISCHEMIC-HEART DISEASE [J].

DREYFUSS, F ;

ZAHAVI, J .

ATHEROSCLEROSIS, 1973, 17 (01) :107-120

[7] RECEPTOR-BINDING PROFILE OF R-41-468, A NOVEL ANTAGONIST AT 5-HT2 RECEPTORS [J].

LEYSEN, JE ;

AWOUTERS, F ;

KENNIS, L ;

LADURON, PM ;

VANDENBERK, J ;

JANSSEN, PAJ .

LIFE SCIENCES, 1981, 28 (09) :1015-1022

[8] PLATELETS AND PROSTAGLANDINS IN CORONARY-ARTERY DISEASE - RATIONALE FOR USE OF PLATELET-SUPPRESSIVE DRUGS [J].

MEHTA, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (20) :2818-2823

[9]

SCHWARTZ MB, 1980, THROMB HAEMOSTASIS, V43, P185

[10]

Van Nueten J. M., 1987, NEW CARDIOVASCULAR D, P1

← 1 2 →